GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: NUAN
Buy

Nuance Communications, Inc. (NASDAQ: NUAN) reiterated to Buy by Standpoint Research

Monday,  Jan 18, 2016  8:25 AM ET by Betsy O'Brien Harrison

Standpoint Research reiterated Nuance Communications, Inc. (NASDAQ: NUAN) to Buy.
Previously Standpoint Research reiterated Nuance Communications, Inc. (NASDAQ: NUAN) to Buy on 01/15/2016, when the stock price was $18.23.

Nuance Communications, Inc. (Nuance) is a provider of speech, imaging and keypad solutions for businesses, organizations and consumers worldwide. The Company?s solutions are used for tasks and services, such as requesting information from a phone-based, self-service solution, dictating medical records, searching the mobile Web by voice, entering a destination into a navigation system, or working with portable document format (PDF) documents. It markets and distributes its products through a global network of resellers, including system integrators, independent software vendors, value-added resellers, hardware vendors, telecommunications carriers and distributors, and also sells directly through sales force and through its Website. In October 2008, the Company acquired SNAPin, Inc., a developer of self-service software for mobile devices. In June 2009, it acquired X-Solutions Group B.V. In September 2009, the Company acquired eCopy, Inc.

Standpoint Research provides independent equity research that is free from the conflicts of asset management, investment banking, proprietary trading, and fee-for-research arrangements. We provide thorough analysis, diagnostics and forecasts on domestic and international equities and markets backed by alpha-generating variables back-tested on many years of data. Standpoint Research currently advises and sells its research to pension funds, hedge funds and asset management firms. Wall Street analysts have an optimistic bias, while we are more objective. In fact some of the variables in our model that are looked at as positives by Wall Street actually carry negative weight in our model. We have a strict discipline that includes running our proprietary 155-variable valuation and diagnostics model with a personal and subjective overlay that has been proven to add value. The effectiveness is demonstrated through our impressive track record of recommendations.



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy